CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that members of its executive team will participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2 at 4:30 PM EST.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The Piper Sandler Healthcare Conference will take place December 2-4, 2025, in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com
Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through…
SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- Global smart technology brand MOVA hosted its…
SAN JOSE, Calif., Jan. 15, 2026 /PRNewswire/ -- LEADOPTIK, Inc. today announced U.S. Food and…
The Miami Beach-based practice integrates the newly approved oral GLP-1 into its physician-supervised weight management…
Nationally recognized healthcare leaders will bring fresh insight to advance NCQA's work in quality and…
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia,…